• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学、UHPLC指纹图谱及血清药物化学整合的山茱萸质量标志物研究

Study on Quality Markers of Chebulae Fructus Immaturus by the Integration of Network Pharmacology, UHPLC Fingerprint, and Serum Pharmacochemistry.

作者信息

Li Qian-Qian, Yang Ru, Luo Xing-Ping, Chen Juan

机构信息

School of Pharmacy, Lanzhou University, Lanzhou, China.

School of Chemical Engineering, Northwest Minzu University, Lanzhou, China.

出版信息

J Sep Sci. 2025 Jul;48(7):e70199. doi: 10.1002/jssc.70199.

DOI:10.1002/jssc.70199
PMID:40583293
Abstract

The chemical composition of Chebulae Fructus Immaturus, a traditional Chinese medicine, is complex. Its efficacy relies on the interaction of its components, making quality evaluation based on a single chemical insufficient. This study proposes a multi-dimensional feature network to enhance Chebulae Fructus Immaturus quality assessment, focusing on effectiveness, content, traceability, and specificity. The network pharmacological analysis is employed to elucidate the underlying mechanism by which chemical components in Chebulae Fructus Immaturus exert their therapeutic effects, specifically in terms of heat-clearing, body fluid promotion, and detoxification. UHPLC fingerprinting analysis can systematically parse the overall chemical profile of Chebulae Fructus Immaturus, and in combination with chemometric analysis, based on the screening criterion of variable importance projection value > 1, nine potential differential compounds in Chebulae Fructus Immaturus were screened out from the chemometric analysis. Subsequently, the UHPLC-QTOF-MS method, which features high sensitivity, high selectivity, high precision and is capable of multi-stage mass spectrometry, was employed to qualitatively identify the aforementioned potential differential compounds to accurately reveal the chemical constituents of Chebulae Fructus Immaturus. The rat serum was subjected to pharmacochemical analysis, which revealed the presence of nine prototype components that were absorbed into the bloodstream. The candidate components were identified and the scores for four dimensions were computed, leading to the construction of a multi-dimensional feature network based on the "spider web" model. Key quality markers in Chebulae Fructus Immaturus were identified as ellagic acid, chebulic acid, methyl gallate, and gallic acid. In conjunction with our prior research on the quality markers of Chebulae Fructus. The binding ability of quality markers in Chebulae Fructus Immaturus and Chebulae Fructus to their corresponding core targets was verified using molecular docking. This multi-dimensional approach founded on advanced analytical methods is capable of accurately identifying and validating key Chebulae Fructus Immaturus quality markers.

摘要

中药西青果化学成分复杂,其药效依赖于各成分间的相互作用,仅基于单一化学成分进行质量评价是不够的。本研究提出一种多维特征网络以加强西青果的质量评估,重点关注有效性、含量、可追溯性和特异性。采用网络药理学分析阐明西青果化学成分发挥治疗作用的潜在机制,特别是在清热、生津和解毒方面。超高效液相色谱指纹图谱分析可系统解析西青果的整体化学特征,并结合化学计量学分析,基于变量重要性投影值>1的筛选标准,从化学计量学分析中筛选出9种西青果潜在差异化合物。随后,采用具有高灵敏度、高选择性、高精度且能进行多级质谱分析的超高效液相色谱-四极杆飞行时间质谱联用(UHPLC-QTOF-MS)方法对上述潜在差异化合物进行定性鉴定,以准确揭示西青果的化学成分。对大鼠血清进行药物化学分析,结果显示有9种原型成分被吸收入血。对候选成分进行鉴定并计算四个维度的得分,基于“蜘蛛网”模型构建多维特征网络。确定西青果的关键质量标志物为鞣花酸、诃子酸、没食子酸甲酯和没食子酸。结合我们之前对诃子质量标志物的研究,利用分子对接验证了西青果和诃子中质量标志物与其相应核心靶点的结合能力。这种基于先进分析方法的多维方法能够准确识别和验证西青果关键质量标志物。

相似文献

1
Study on Quality Markers of Chebulae Fructus Immaturus by the Integration of Network Pharmacology, UHPLC Fingerprint, and Serum Pharmacochemistry.基于网络药理学、UHPLC指纹图谱及血清药物化学整合的山茱萸质量标志物研究
J Sep Sci. 2025 Jul;48(7):e70199. doi: 10.1002/jssc.70199.
2
An Integrative Strategy for Discriminating Quality Markers of Tibetan Medicine Chebulae Fructus Based on Multidimensional Feature Network.基于多维特征网络鉴别藏药诃子质量标志物的整合策略
Phytochem Anal. 2025 Apr;36(3):732-743. doi: 10.1002/pca.3463. Epub 2024 Nov 10.
3
Comprehensive Profiling of Chemical Constituents and Metabolites of the Angelica sinensis-Sophora flavescens Herbal Pair in Plasma and Urine via UHPLC-Q-TOF-MS Coupled With Multi-Platform Data Integration.基于UHPLC-Q-TOF-MS联用多平台数据整合技术对当归-苦参药对血浆和尿液中化学成分及代谢产物的全面分析
J Sep Sci. 2025 Jun;48(6):e70201. doi: 10.1002/jssc.70201.
4
An integrated strategy for deciphering quality markers of Terminaliae Belliricae Fructus based on a three-dimensional characteristic model.基于三维特征模型的诃子品质标志物解析的整体策略。
J Chromatogr A. 2024 Nov 22;1737:465465. doi: 10.1016/j.chroma.2024.465465. Epub 2024 Oct 22.
5
Phytochemical Analysis of Semen Hoveniae and Its Potential Mechanism Against Alcoholic Liver Disease via an Integrated Approach Combining UHPLC-Q-TOF MS, Network Pharmacology, and Molecular Docking.枳椇子的植物化学分析及其通过UHPLC-Q-TOF MS、网络药理学和分子对接相结合的综合方法对抗酒精性肝病的潜在机制
Rapid Commun Mass Spectrom. 2025 Oct 30;39(20):e10097. doi: 10.1002/rcm.10097.
6
The mechanism of Chebulae Fructus Immaturus promote diabetic wound healing based on network pharmacology and experimental verification.基于网络药理学和实验验证的诃子未熟果实促进糖尿病创面愈合的机制。
J Ethnopharmacol. 2024 Mar 25;322:117579. doi: 10.1016/j.jep.2023.117579. Epub 2023 Dec 15.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Integrated metabolomics and serum-feces pharmacochemistry-based network pharmacology to reveal the mechanisms of an herbal prescription against ulcerative colitis.基于整合代谢组学和血清-粪便药代动力学的网络药理学揭示治疗溃疡性结肠炎的中药复方作用机制。
Comput Biol Med. 2024 Aug;178:108775. doi: 10.1016/j.compbiomed.2024.108775. Epub 2024 Jun 27.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.